Becton, Dickinson & Co. (BDX)
198.86
+10.04
(+5.32%)
USD |
NYSE |
Dec 10, 15:30
Becton, Dickinson EPS Diluted (Quarterly): 1.717 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| ResMed, Inc. | 2.373 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Solventum Corp. | 7.218 |
| Accuray, Inc. | -0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 493.00M |
| Revenue (Quarterly) | 5.89B |
| Total Expenses (Quarterly) | 5.397B |
| Enterprise Value | 73.05B |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 8.37% |
| Earnings Yield | 2.93% |
| Operating Earnings Yield | 5.38% |
| Normalized Earnings Yield | -0.5581 |